Wharton’s jelly–derived mesenchymal stem cells (WJ-MSCs)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Wharton’s jelly–derived mesenchymal stem cells (WJ-MSCs), covering 2015-02-13 to 2015-02-13. Get the full timeline:
Most recent: Clinical Trial Update: Intracoronary Human Wharton's Jelly- Derived Mesenchymal Stem Cells (WJ-MSCs) Transfer in Patients With Acute Myocardial Infarction (AMI) [Phase 2]